1. New vaccine technology may be put to test with COVID-19 — FDA rejects Merck's 6-week Keytruda dosing schedule — Blood disorder startup Imara files for $86M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

SAREPTA Therpauetics BUYOUT

Discussion in 'Industry Rumors' started by anonymous, Mar 22, 2016 at 6:58 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Which Pharma takes
     

  2. anonymous

    anonymous Guest

    Duchenne mD is a gold mine- cash cow
     
  3. anonymous

    anonymous Guest

    Biomarin and Sarepta a perfect fit